Comments

AIM ImmunoTech Stock Price, Quotes and Forecasts

Q: What sector and industry does AIM ImmunoTech (AIM) operate in?

AIM ImmunoTech is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

AIMAMEX

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.1404

-0.00160-1.13%

At close: -

$0.1379

-0.00250-1.78%

After Hours: 5:31 PM EDT

AIM ImmunoTech (AIM) Forecast

News Earnings AIM ImmunoTech (AIM) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

AIM ImmunoTech Stock Price, Quotes and Forecasts | AMEX:AIM | Benzinga

Explore AIM ImmunoTech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AIM.

Open	$0.14
Close	$0.14
Volume / Avg.	325.44K / 1.06M
Day Range	$0.13 - $0.14
52 Wk Range	0.11 - 0.62
Market Cap	$9.48M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	51
Short Interest	5.19%
Days to Cover	2.88

Recent News

AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying

The Dow Jones index closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying

The Dow Jones closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones closed lower by more than 150 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.14
Close	$0.14
Volume / Avg.	325.44K / 1.06M
Day Range	$0.13 - $0.14
52 Wk Range	0.11 - 0.62
Market Cap	$9.48M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	51
Short Interest	5.19%
Days to Cover	2.88

About AIM ImmunoTech Inc

Sector

Health Care

Industry

Biotechnology

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics t...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy AIM ImmunoTech (AIM) stock?

You can purchase shares of AIM ImmunoTech (AMEX:AIM) through any online brokerage.

View our list of the best stock brokerages

Who are AIM ImmunoTech (AIM) competitors?

Other companies in AIM ImmunoTech’s space includes: Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), Evaxion Biotech (NASDAQ:EVAX) and Can Fite Biofarma (AMEX:CANF).

What is the forecast, or price target, for AIM ImmunoTech (AIM) stock?

AIM ImmunoTech has a consensus price target of $2.75.

What is the current price for AIM ImmunoTech (AIM)?

The stock price for AIM ImmunoTech (AMEX: AIM) is $0.1379 last updated March 24, 2025 at 5:31 PM EDT.

Does AIM ImmunoTech (AIM) pay a dividend?

There are no upcoming dividends for AIM ImmunoTech.

When is AIM ImmunoTech (AMEX:AIM) reporting earnings?

AIM ImmunoTech’s Q1 earnings are confirmed for Thursday, May 15, 2025.

Is AIM ImmunoTech (AIM) going to split?

There is no upcoming split for AIM ImmunoTech.

What sector and industry does AIM ImmunoTech (AIM) operate in?

AIM ImmunoTech is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.